SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
张大宝
Lv2
160 积分
2021-04-07 加入
最近求助
最近应助
互助留言
Trifluridine–tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 study
2天前
已完结
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
1个月前
已完结
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma
1个月前
已完结
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
1个月前
已完结
189P Safety run-in results from LEAP-014: First-line lenvatinib (len) plus pembrolizumab (pembro) and chemotherapy (chemo) for metastatic esophageal squamous cell carcinoma (ESCC)
1个月前
已完结
1534P First-line lenvatinib (len) plus pembrolizumab (pembro) and chemotherapy (chemo) for metastatic esophageal squamous cell carcinoma (mESCC): Safety run-in results from the phase III LEAP-014 study
1个月前
已完结
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
1个月前
已完结
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
2个月前
已完结
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2个月前
已完结
1534P First-line lenvatinib (len) plus pembrolizumab (pembro) and chemotherapy (chemo) for metastatic esophageal squamous cell carcinoma (mESCC): Safety run-in results from the phase III LEAP-014 study
2个月前
已完结
没有进行任何应助
感谢,点赞,速度真快,帮大忙了
2天前
感谢,点赞,速度真快,帮大忙了,么么哒
1个月前
感谢,点赞,速度真快,帮大忙了,么么哒
1个月前
感谢,点赞,速度真快,帮大忙了,么么哒
1个月前
感谢,点赞,速度真快,速度真快,帮大忙了
1个月前
感谢,点赞,速度真快,帮大忙了,么么哒
1个月前
感谢,点赞,速度真快,帮大忙了,么么哒
1个月前
感谢,点赞,速度真快,帮大忙了,么么哒
2个月前
感谢,点赞
2个月前
感谢,点赞,速度真快,么么哒,帮大忙了
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论